Chitooligosaccharide reconstitutes intestinal mucus layer to improve oral absorption of water-soluble drugs

IF 10.5 1区 医学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Yiming Qi , Ming Jin , Qing Li , Qinghua Wu , Zhiqian Liao , Menghao Wei , Xinyi Fan , Qianzhan Yang , Xiaohe Tian , Battaglia Giuseppe , Lei Luo
{"title":"Chitooligosaccharide reconstitutes intestinal mucus layer to improve oral absorption of water-soluble drugs","authors":"Yiming Qi ,&nbsp;Ming Jin ,&nbsp;Qing Li ,&nbsp;Qinghua Wu ,&nbsp;Zhiqian Liao ,&nbsp;Menghao Wei ,&nbsp;Xinyi Fan ,&nbsp;Qianzhan Yang ,&nbsp;Xiaohe Tian ,&nbsp;Battaglia Giuseppe ,&nbsp;Lei Luo","doi":"10.1016/j.jconrel.2023.07.035","DOIUrl":null,"url":null,"abstract":"<div><p>Intestinal mucus is a complex natural hydrogel barrier with unique physical properties that impede the absorption of various oral drugs. Both washout from the upper water layer and the physical resistance of the mucus layer particularly affect bioavailability of, especially, highly water-soluble molecules. One potential strategy for designing pharmaceutical formulations is to add absorption enhancers (AEs). However, there are few reports of AEs that work on mucus and their underlying mechanisms, leading to imprecise application. In this study, we investigated chitooligosaccharide (COS) as a safe, low-cost, and effective oral drug AE. We revealed the hydrodynamic<span> law of interaction between COS and the intestinal mucus layer, which was associated with absorption benefiting mucus structural reconstruction. Based on this, we designed a translational strategy to improve the bioavailability of a group of soluble oral drugs by drinking COS solution before administration. Moreover, this research is expected to expand its application scenario by reducing drug dosage such as avoiding gastro-intestinal irritation and slowing veterinary antibiotic resistance.</span></p></div>","PeriodicalId":15450,"journal":{"name":"Journal of Controlled Release","volume":"360 ","pages":"Pages 831-841"},"PeriodicalIF":10.5000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Controlled Release","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168365923004595","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Intestinal mucus is a complex natural hydrogel barrier with unique physical properties that impede the absorption of various oral drugs. Both washout from the upper water layer and the physical resistance of the mucus layer particularly affect bioavailability of, especially, highly water-soluble molecules. One potential strategy for designing pharmaceutical formulations is to add absorption enhancers (AEs). However, there are few reports of AEs that work on mucus and their underlying mechanisms, leading to imprecise application. In this study, we investigated chitooligosaccharide (COS) as a safe, low-cost, and effective oral drug AE. We revealed the hydrodynamic law of interaction between COS and the intestinal mucus layer, which was associated with absorption benefiting mucus structural reconstruction. Based on this, we designed a translational strategy to improve the bioavailability of a group of soluble oral drugs by drinking COS solution before administration. Moreover, this research is expected to expand its application scenario by reducing drug dosage such as avoiding gastro-intestinal irritation and slowing veterinary antibiotic resistance.

Abstract Image

壳寡糖重建肠道黏液层,改善水溶性药物的口服吸收
肠道粘液是一种复杂的天然水凝胶屏障,具有独特的物理性质,阻碍各种口服药物的吸收。上层水层的冲刷和黏液层的物理阻力都特别影响生物利用度,特别是高水溶性分子。设计药物配方的一个潜在策略是添加吸收促进剂(ae)。然而,很少有关于ae作用于粘液及其潜在机制的报道,导致应用不精确。在这项研究中,我们研究了壳寡糖(COS)作为一种安全、低成本、有效的口服药物AE。我们揭示了COS与肠道黏液层相互作用的流体动力学规律,该规律与吸收有利于黏液结构重建有关。在此基础上,我们设计了一种通过给药前饮用COS溶液提高可溶性口服药物生物利用度的转化策略。此外,本研究有望通过减少药物剂量,如避免胃肠道刺激和减缓兽医抗生素耐药性,扩大其应用场景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Controlled Release
Journal of Controlled Release 医学-化学综合
CiteScore
18.50
自引率
5.60%
发文量
700
审稿时长
39 days
期刊介绍: The Journal of Controlled Release (JCR) proudly serves as the Official Journal of the Controlled Release Society and the Japan Society of Drug Delivery System. Dedicated to the broad field of delivery science and technology, JCR publishes high-quality research articles covering drug delivery systems and all facets of formulations. This includes the physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries. Priority is given to manuscripts that contribute to the fundamental understanding of principles or demonstrate the advantages of novel technologies in terms of safety and efficacy over current clinical standards. JCR strives to be a leading platform for advancements in delivery science and technology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信